Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,929,830
in 12 filings, $348K under 10b5-1 plans

Net +$2,318,700. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-05-12 Hasnain Faheem Director Grant or award · Option to purchase common stock +10,000 10,000
2016-01-29 WILSON TROY EDWARD President and CEO Grant or award · Option to purchase common stock +125,000 125,000
2016-01-29 REN PINGDA SVP-Chemistry&Pharma Sciences Grant or award · Option to purchase common stock +50,000 50,000
2016-01-29 LIU YI Chief Scientific Officer Grant or award · Option to purchase common stock +50,000 50,000
2016-01-29 North Annette SVP, General Counsel Grant or award · Option to purchase common stock +80,000 80,000
2016-01-29 GUALBERTO ANTONIO Chief Medical Officer Grant or award · Option to purchase common stock +75,000 75,000
2016-01-29 HENSON HEIDI Chief Financial Officer Grant or award · Option to purchase common stock +80,000 80,000
2016-01-29 WILSON TROY EDWARD President and CEO Grant or award · Option to purchase common stock +120,000 120,000
2015-11-10 Malley Thomas Director Purchase +50,000 $8.00 $400K 89,557
2015-10-13 Malley Thomas Director Grant or award · Option to purchase common stock +30,000 30,000
2015-04-23 HOFFMAN ROBERT Director Grant or award · Option to purchase common stock +30,000 30,000
2015-04-23 North Annette SVP, General Counsel Grant or award · Option to purchase common stock +81,250 81,250
2015-04-23 Hasnain Faheem Director Grant or award · Option to purchase common stock +30,000 30,000
2015-03-06 PAPPAJOHN JOHN President Returned to the company −2,000,000 0
2015-03-06 VASSILIOU ARGYRIS 10% owner Returned to the company −625,000 0
2015-03-06 VASSILIOU ARGYRIS 10% owner Returned to the company −375,000 0
2015-03-06 KINLEY MATTHEW P Secretary, CFO Returned to the company −2,000,000 0

Page 21 of 21 · 417 trades